Assessment of artificial intelligence-aided chest computed tomography in diagnosis of chronic obstructive airway disease: an observational study

Author:

Saad Maha M.ORCID,Bayoumy Ahmed A.,EL-Nisr Magdy M.,Zaki Noha M.,Khalil Tarek H.,ELSerafi Ahmed F.

Abstract

Abstract Background The Global Initiative for Obstructive Lung Disease (GOLD) staging approach is frequently used to classify the severity of COPD by using spirometry. Recent advancements in artificial intelligence applications enable the automatic identification of COPD severity by chest computer tomography (CT). The goal of this study is to define the role of artificial intelligence in determining the severity of COPD. Methods  We used a non-contrast CT chest and a computer-aided detection system (Coreline Soft's AVIEW), which was conducted as a descriptive cross sectional study and involved 80 cases. For the diagnosis of parenchymal disease using density mask methods such as inspiratory low attenuation area-950% (%LAA-950 HUINS) and D-value (cluster-size analysis), the spirometry-based Tiffeneau index (TI; calculated as the ratio of forced expiratory volume in the first second (FEV1) to forced vital capacity was used to assess the severity of COPD. Results  Based on the results of the spirometry, the patients were divided into four groups: mild (n = 23), moderate (n = 39), severe (n = 17), and very severe (n = 1). Insp. LAA-950 (%) in GOLD group 3 was substantially greater than in GOLD groups 2 and 1. Additionally, when compared to groups 2 and 1, the D-value in the GOLD 3 group was significantly higher. Conclusions Inspiratory LAA-950% and D-value were found to be significantly related to COPD severity as measured by dyspnea scale and spirometry. Inspiratory LAA-950% was effectively capable of distinguishing between patients with severe and moderate COPD.

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging

Reference33 articles.

1. Wang S, Summers RM (2012) Machine learning and radiology. Med Image Anal 16(5):933–951

2. Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A et al (2013) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 187(4):347–365

3. WHO. Chronic obstructive pulmonary disease (COPD): WHO; 2022 [updated 20 May 2022. Available from: https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd).

4. Richter DC, Joubert JR, Nell H, Schuurmans MM, Irusen EM (2008) Diagnostic value of post-bronchodilator pulmonary function testing to distinguish between stable, moderate to severe COPD and asthma. Int J Chronic Obstr Pulm Dis 3(4):693

5. Heussel C, Herth F, Kappes J, Hantusch R, Hartlieb S, Weinheimer O et al (2009) Fully automatic quantitative assessment of emphysema in computed tomography: comparison with pulmonary function testing and normal values. Eur Radiol 19(10):2391–2402

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3